CLINICAL_TRIALS
trial_result
· 2014-05-20
Clinical Trial Update: Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis
Summary
The study evaluated copeptin as a diagnostic biomarker for managing neurosurgical patients with disturbances in water balance related to pituitary adenoma. The …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Basel, Switzerland | Conditions: Pituitary Adenoma | Status: COMPLETED